Application of Rowatinex in the perioperative period in the extracorporeal shock wave lithotripsy


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Despite the high efficacy and safety of ESWL used to disintegrate stones in pyelocaliceal system and upper ureter, the issue of further reduction of the risk of complications of this procedure remains unresolved. The inclusion of phytopreparations with anti-inflammatory and lithokinetic properties in the scheme of perioperative treatment is one of the ways for prevent complications of ESWL. The effect of the drug Rowatinex on the process of discharge of calculi fragments after ESWL is evaluated. The frequency and intensity of qualitative changes of urine after appointment this drug were assessed. It is concluded that Rowatinex has positive impact on the final result of ESWL in the case of its inclusion in the complex medical treatment, which manifests in terms of reducing the time of discharge of fragments, mitigation of subjective symptoms, as well as reducing the frequency of subclinical bacteriuria and severe complications.

Full Text

Restricted Access

About the authors

V. M Popkov

Saratov State Medical University n.a. V.I. Razumovsky; Scientific Research Institute of Fundamental and Clinical Uronephrology

B. I Blumberg

Saratov State Medical University n.a. V.I. Razumovsky; Scientific Research Institute of Fundamental and Clinical Uronephrology

O. V Osnovin

Saratov State Medical University n.a. V.I. Razumovsky; Scientific Research Institute of Fundamental and Clinical Uronephrology

T. V Shatylko

Saratov State Medical University n.a. V.I. Razumovsky; Scientific Research Institute of Fundamental and Clinical Uronephrology

Email: shatylko@sar-urology.ru

References

  1. Engel R.M. De Historia Lithotomiae [электронный ресурс] / UROlog: the urology website // URL: http://www.urolog.nl/ urolog/php/content.php?doc=lithotomia&profmenu=yes (дата обращения: 19.02.2014).
  2. Burns E.M. Extracorporeal Shock Wave Lithotripsy [электронный ресурс, лекция] / Medical University of South Carolina, Department of Urology // URL: http://clinicaldepartments.musc. edu/urology/students/Extracorporeal%20Shock%20Wave%20 Lithotripsy.pdf (дата обращения: 19.02.2014).
  3. Tailly G.G. Extracorporeal shock wave lithotripsy today. Indian J Urol. 2013;29(3):200-207.
  4. Skolarikos A., Alivizatos G., de la Rosette J. Extracorporeal Shock Wave Lithotripsy 25 Years Later: Complications and Their Prevention. Eur. Urol. 2006;50: 981-990.
  5. Сивков А.В., Дзеранов Н.К., Константинова О.В. и др. Применение препарата «Роватинекс» у пациентов, страдающих уролитиазом. Бюллетень мед. интернет-конф. 2011; 1(4): 222-236.
  6. Romics I., Siller G., Kohnen R. et al. A special terpene combination (Rowatinex®) improves stone clearance after extracorporeal shockwave lithotripsy in urolithiasis patients: results of a placebo-controlled randomised controlled trial. Urol. Int. 2011; 86(1): 102-109.
  7. Основин О.В., Попков В.М., Блюмберг Б.И. и др. Результаты применения электрокондуктивной дистанционной литотрипсии на аппарате «Sonolith i-sys» в лечении больных уролитиазом. Мед. вестник Башкортостана. 2013;8(2): 316-318.
  8. Lee J.W., Lee M.Y., Park S.C. et al. In vitro Study on Ureteral Smooth Muscle Relaxation with Tamsulosin, Nifedipine, and Terpene mixure (Rowatinex®). Eur. Urol. 2013; 12(1) Supp.: 17.
  9. Mata R., Rojas A., Acevedo L. Smooth muscle relaxing flavonoids and terpenoids from Conyza filaginoides. Planta Med. 1997; 63(1): 31-35.
  10. Chua M.E., Park J.H., Castillo J.C. Terpene compound drug as medical expulsive therapy for ureterolithiasis: a meta-analysis. Urolithiasis. 2013;41(2):143-151.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2014 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies